ICU Medical, Inc.ICUINASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank46
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P46
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 qtr
Consecutive growthRecovering
PeriodValue
Q4 2025-0.78%
Q3 2025-2.82%
Q2 2025-6.11%
Q1 20254.19%
Q4 20246.31%
Q3 2024-10.10%
Q2 20247.09%
Q1 2024-2.54%
Q4 20237.38%
Q3 2023-6.42%
Q2 202312.86%
Q1 2023-15.72%
Q4 20221.48%
Q3 20222.41%
Q2 2022-5.48%
Q1 202281.31%
Q4 20217.58%
Q3 20217.49%
Q2 20216.31%
Q1 2021-9.22%
Q4 202016.50%
Q3 2020-1.49%
Q2 2020-4.35%
Q1 2020-14.63%
Q4 20194.87%
Q3 20197.17%
Q2 2019-12.66%
Q1 2019-5.19%
Q4 20182.61%
Q3 2018-2.90%
Q2 20187.86%
Q1 2018-9.30%
Q4 20178.67%
Q3 2017-1.53%
Q2 201711.39%
Q1 2017338.62%
Q4 2016-27.29%
Q3 20169.35%
Q2 20160.75%
Q1 2016-18.34%